Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie Ewer, Geraldine O’Hara, C.J. Duncan, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 283

Showing 51-75 of 283 citing articles:

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
Alfred B. Tiono, Issa Nèbiè, Nicholas Anagnostou, et al.
PLoS ONE (2018) Vol. 13, Iss. 12, pp. e0208328-e0208328
Open Access | Times Cited: 59
Assessment of Humoral Immune Responses to Blood-Stage Malaria Antigens following ChAd63-MVA Immunization, Controlled Human Malaria Infection and Natural Exposure
Sumi Biswas, Prateek Choudhary, Sean C. Elias, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107903-e107903
Open Access | Times Cited: 65
Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
Martha Sedegah, Michael R. Hollingdale, Fouzia Farooq, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e106241-e106241
Open Access | Times Cited: 61
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
Muhammed O. Afolabi, Alfred B. Tiono, Uche J. Adetifa, et al.
Molecular Therapy (2016) Vol. 24, Iss. 8, pp. 1470-1477
Open Access | Times Cited: 59
Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines
Tomáš Hanke
Expert Opinion on Biological Therapy (2014) Vol. 14, Iss. 5, pp. 601-616
Closed Access | Times Cited: 58
CD8 T-cell-mediated protection against liver-stage malaria: lessons from a mouse model
Natalija Budimir, John T. Harty
Frontiers in Microbiology (2014) Vol. 5
Open Access | Times Cited: 57
Vector-based genetically modified vaccines: Exploiting Jenner’s legacy
Bahar Ramezanpour, Ingrid Haan, Ab Osterhaus, et al.
Vaccine (2016) Vol. 34, Iss. 50, pp. 6436-6448
Open Access | Times Cited: 57
Immune Responses in Malaria
Carole A. Long, Fidel Zavala
Cold Spring Harbor Perspectives in Medicine (2017) Vol. 7, Iss. 8, pp. a025577-a025577
Open Access | Times Cited: 57
Memory B-Cell and Antibody Responses Induced by Plasmodium falciparum Sporozoite Immunization
Wiebke Nahrendorf, Anja Scholzen, Else M. Bijker, et al.
The Journal of Infectious Diseases (2014) Vol. 210, Iss. 12, pp. 1981-1990
Open Access | Times Cited: 56
Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
Katie Ewer, Kailan Sierra-Davidson, Ahmed M. Salman, et al.
Vaccine (2015) Vol. 33, Iss. 52, pp. 7444-7451
Open Access | Times Cited: 56
Prime-and-Trap Malaria Vaccination To Generate Protective CD8+ Liver-Resident Memory T Cells
Tayla M. Olsen, Brad Stone, Vorada Chuenchob, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 7, pp. 1984-1993
Open Access | Times Cited: 56
Translating the Immunogenicity of Prime-boost Immunization With ChAd63 and MVA ME-TRAP From Malaria Naive to Malaria-endemic Populations
Domtila Kimani, Ya Jankey Jagne, Momodou Cox, et al.
Molecular Therapy (2014) Vol. 22, Iss. 11, pp. 1992-2003
Open Access | Times Cited: 53
Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates
Rhea J. Longley, Ahmed M. Salman, Matthew G. Cottingham, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 53
Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45
Michael Pritsch, Najib Ben-Khaled, Michael Chaloupka, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-11
Open Access | Times Cited: 52
Status of vaccine research and development of vaccines for malaria
Ashley J. Birkett
Vaccine (2016) Vol. 34, Iss. 26, pp. 2915-2920
Open Access | Times Cited: 52
Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells
Nicholas M. Provine, Rafael A. Larocca, Malika Aïd, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 5, pp. 1809-1822
Open Access | Times Cited: 51
Repeated clinical malaria episodes are associated with modification of the immune system in children
Yaw Bediako, Rhys Adams, Adam J. Reid, et al.
BMC Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer
Federica Cappuccini, Stephen M. Stribbling, Emily Pollock, et al.
Cancer Immunology Immunotherapy (2016) Vol. 65, Iss. 6, pp. 701-713
Open Access | Times Cited: 49
Protective immunity to liver‐stage malaria
Lauren E. Holz, Daniel Fernandez‐Ruiz, William R. Heath
Clinical & Translational Immunology (2016) Vol. 5, Iss. 10
Open Access | Times Cited: 49
Vaccines against Ebola virus
Navin Venkatraman, Daniel Silman, Pedro M. Folegatti, et al.
Vaccine (2017) Vol. 36, Iss. 36, pp. 5454-5459
Open Access | Times Cited: 49
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal
Victorine A. Mensah, Aly Gueye, Magatte Ndiaye, et al.
PLoS ONE (2016) Vol. 11, Iss. 12, pp. e0167951-e0167951
Open Access | Times Cited: 48
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
Tommy Rampling, Katie Ewer, Georgina Bowyer, et al.
npj Vaccines (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 47
Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
Hazel M. Dockrell, Helen McShane
EBioMedicine (2022) Vol. 79, pp. 103993-103993
Open Access | Times Cited: 24
Adenoviral vaccines—Infectious disease
Carly M. Bliss, Gerardo Montalvo Zurbia-Flores, Daniel Wright, et al.
Elsevier eBooks (2025), pp. 573-642
Closed Access
Adenoviral vaccines: COVID-19
Pablo Penaloza‐MacMaster
Elsevier eBooks (2025), pp. 643-655
Closed Access

Scroll to top